Business Context and Reporting Period
This Form 8-K is a current report filed by NanoAntibiotics, Inc. (not Biovie Inc.) on August 25, 2014. The filing addresses a change in the company's independent registered public accounting firm effective as of the report date.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, it notes that the previous auditor's reports for the fiscal year ended June 30, 2013, contained an explanatory paragraph indicating substantial doubt regarding the Company's ability to continue as a going concern.
Material Changes
- Dismissal of Previous Auditor: Messineo & Co, CPAs LLC was dismissed effective August 25, 2014.
- Appointment of New Auditor: Weinberg & Baer LLC was appointed as the new independent registered public accounting firm effective August 25, 2014, to perform auditing services commencing with the fiscal year ending June 30, 2014.
- Audit History: There were no disagreements with the previous auditor regarding accounting principles, practices, or audit scope during the most recent fiscal year or through the date of dismissal.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the previously noted "substantial doubt" regarding the company's ability to continue as a going concern found in the prior auditor's report. No unusual items or contingencies were reported in this specific filing.
Investor Verification Checklist
- Verify the reasons for the change in auditors beyond the standard disclosure.
- Review the "Auditor Letter to SEC" (Exhibit 16.1) to confirm if the dismissed auditor (Messineo) agreed with the company's statements.
- Assess the current status of the "substantial doubt" regarding the company's ability to continue as a going concern.
- Confirm the company's current financial position and liquidity status, as this filing does not provide updated financial data.